Clinical trial
The Effect of Personalised Pharmaconutrition Therapy on Myosteatosis, Sarcopenia and Prognosis in Patients With Gastric Cancer
NCT07466758 is registered in ClinicalTrials.gov with Biruni University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Personalised Pharmaconutrition Therapy on Myosteatosis, Sarcopenia and Prognosis in Patients With Gastric Cancer
- Lead sponsor
- Biruni University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 16, 2024
- Completion date
- March 4, 2026
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
myosteatosis, sarcopenia